Baron Capital Maintains Positive Long-Term Outlook for Intuitive Surgical
Baron Capital predicts mid-teens revenue growth for Intuitive Surgical despite recent stock declines and broader medical device market headwinds.
Baron Capital expressed a positive long-term growth outlook for Intuitive Surgical, Inc. in its second-quarter 2026 investor letter for the Baron Health Care Fund. The firm predicts the company can maintain revenue growth at a mid-teens rate for several years, even as Intuitive Surgical shares declined following first-quarter U.S. system placements that fell below investor expectations.
Baron Capital noted that medical device stocks generally underperformed due to concerns over decelerating health care utilization. The firm specifically cited the expiration of Affordable Care Act subsidies and the potential impact of 2027 Medicaid work requirements as contributing factors to the sector's struggle.
As of August 3, 2026, Intuitive Surgical, Inc. held a market capitalization of $132.62 billion, with a closing share price of $375.41.